WVE (STOCKS)
Wave Life Sciences Ltd. Ordinary Shares
$13.350000
-0.240000 (-1.77%)
Prev close: $13.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul B. Bolno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,453.64M
- Employees
- 288
- P/E (TTM)
- -17.75
- P/B (TTM)
- 17.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.32 | $-0.30 | -0.0187 | -6.21% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.29 | -0.0165 | -5.62% |
|
Mar 2025 (Q1)
|
$-0.29 | $-0.26 | -0.0265 | -10.06% |
|
Dec 2024 (Q4)
|
$0.17 | $-0.18 | +0.3538 | +192.49% |
Financial Statements
| Revenues | $109.23M |
| Benefits Costs and Expenses | $231.18M |
| Costs And Expenses | $226.57M |
| Nonoperating Income/Loss | $14.00M |
| Operating Expenses | $245.18M |
| Research and Development | $174.61M |
| Other Operating Expenses | $70.57M |
| Operating Income/Loss | -$135.95M |
| Income/Loss From Continuing Operations After Tax | -$121.95M |
| Income/Loss From Continuing Operations Before Tax | -$121.95M |
| Net Income/Loss | -$121.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$121.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$121.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.65 |
| Diluted Earnings Per Share | -$0.65 |
| Basic Average Shares | 338,812,179 |
| Diluted Average Shares | 338,812,179 |
| Assets | $241.38M |
| Current Assets | $215.49M |
| Prepaid Expenses | $6.65M |
| Other Current Assets | $208.84M |
| Noncurrent Assets | $25.89M |
| Fixed Assets | $8.20M |
| Other Non-current Assets | $17.69M |
| Liabilities | $108.96M |
| Current Liabilities | $85.90M |
| Accounts Payable | $14.49M |
| Wages | $11.14M |
| Other Current Liabilities | $60.27M |
| Noncurrent Liabilities | $23.06M |
| Equity | $124.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $124.55M |
| Temporary Equity | $7.87M |
| Temporary Equity Attributable To Parent | $7.87M |
| Liabilities And Equity | $241.38M |
| Net Cash Flow From Operating Activities | -$197.37M |
| Net Cash Flow From Operating Activities, Continuing | -$197.37M |
| Net Cash Flow From Investing Activities | -$805.00K |
| Net Cash Flow From Investing Activities, Continuing | -$805.00K |
| Net Cash Flow From Financing Activities | $83.52M |
| Net Cash Flow From Financing Activities, Continuing | $83.52M |
| Net Cash Flow | -$114.65M |
| Net Cash Flow, Continuing | -$114.65M |
| Comprehensive Income/Loss | -$121.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$121.98M |
| Other Comprehensive Income/Loss | -$31.00K |